The Quantitative Medicine team at Critical Path Institute (C-Path) specializes in the application of advanced mathematical and computational techniques to analyze and interpret biomedical data. This team's primary focus is on pharmacometrics to accelerate drug development and regulatory decision-making by creating predictive models and simulations. Their work involves close collaboration with scientists from various sectors to develop quantitative tools that inform clinical trials and regulatory strategies.